Abstract
In a document outlining its regulatory priorities for 2022, the federal Department of Health and Human Services (HHS) is proposing three rules that would extend telehealth flexibilities for substance use disorder treatments. These deregulatory actions were granted during the COVID‐19 public health emergency, but HHS is now focusing on making these permanent.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
